These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7703623

  • 21. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, Marcolongo R.
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.
    Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP.
    J Bone Miner Res; 2000 Jun; 15(6):1006-13. PubMed ID: 10841169
    [Abstract] [Full Text] [Related]

  • 23. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men.
    Evans SF, Davie MW.
    Ann Rheum Dis; 2000 Apr; 59(4):269-75. PubMed ID: 10733473
    [Abstract] [Full Text] [Related]

  • 24. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
    Monadi M, Javadian Y, Cheraghi M, Heidari B, Amiri M.
    Osteoporos Int; 2015 Jul; 26(7):2013-8. PubMed ID: 25860975
    [Abstract] [Full Text] [Related]

  • 25. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 26. In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
    Rigalli A, Pera L, Morosano M, Masoni A, Bocanera R, Tozzini R, Puche RC.
    Medicina (B Aires); 1999 Jan; 59(2):157-61. PubMed ID: 10413893
    [Abstract] [Full Text] [Related]

  • 27. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
    Reid DM, Adami S, Devogelaer JP, Chines AA.
    Calcif Tissue Int; 2001 Oct; 69(4):242-7. PubMed ID: 11730260
    [Abstract] [Full Text] [Related]

  • 28. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes.
    Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, Johnson KA, Melton LJ.
    J Clin Invest; 1982 Oct; 70(4):716-23. PubMed ID: 7119111
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of monthly ibandronate in men with low bone density.
    Orwoll ES, Binkley NC, Lewiecki EM, Gruntmanis U, Fries MA, Dasic G.
    Bone; 2010 Apr; 46(4):970-6. PubMed ID: 20060082
    [Abstract] [Full Text] [Related]

  • 30. Bone mineral density in women with systemic lupus erythematosus.
    Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E.
    Clin Rheumatol; 2002 May; 21(2):135-41. PubMed ID: 12086164
    [Abstract] [Full Text] [Related]

  • 31. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH.
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.
    Lems WF, Jacobs WG, Bijlsma JW, Croone A, Haanen HC, Houben HH, Gerrits MI, van Rijn HJ.
    Osteoporos Int; 1997 Jul; 7(6):575-82. PubMed ID: 9604055
    [Abstract] [Full Text] [Related]

  • 34. Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer.
    Rizzoli R, Forni M, Schaad MA, Slosman DO, Sappino AP, Garcia J, Bonjour JP.
    Bone; 1996 Jun; 18(6):531-7. PubMed ID: 8805993
    [Abstract] [Full Text] [Related]

  • 35. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.
    Popp AW, Guler S, Lamy O, Senn C, Buffat H, Perrelet R, Hans D, Lippuner K.
    J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784
    [Abstract] [Full Text] [Related]

  • 36. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
    Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3076-81. PubMed ID: 17566094
    [Abstract] [Full Text] [Related]

  • 37. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K.
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [Abstract] [Full Text] [Related]

  • 38. A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.
    Affinito P, Di Carlo C, Primizia M, Petrillo G, Napolitano V, Tremolaterra F, Nappi C.
    Gynecol Endocrinol; 1993 Sep; 7(3):201-5. PubMed ID: 8291458
    [Abstract] [Full Text] [Related]

  • 39. Proton pump inhibitors use and change in bone mineral density.
    Arj A, Razavi Zade M, Yavari M, Akbari H, Zamani B, Asemi Z.
    Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
    [Abstract] [Full Text] [Related]

  • 40. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N, Legroux I, Hazzan M, Noel C, Cortet B.
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.